1. Home
  2. IMMP vs NGS Comparison

IMMP vs NGS Comparison

Compare IMMP & NGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMP
  • NGS
  • Stock Information
  • Founded
  • IMMP 1987
  • NGS 1998
  • Country
  • IMMP Australia
  • NGS United States
  • Employees
  • IMMP N/A
  • NGS N/A
  • Industry
  • IMMP Biotechnology: Pharmaceutical Preparations
  • NGS Oilfield Services/Equipment
  • Sector
  • IMMP Health Care
  • NGS Energy
  • Exchange
  • IMMP Nasdaq
  • NGS Nasdaq
  • Market Cap
  • IMMP 251.8M
  • NGS 305.2M
  • IPO Year
  • IMMP N/A
  • NGS 2002
  • Fundamental
  • Price
  • IMMP $1.67
  • NGS $26.76
  • Analyst Decision
  • IMMP Buy
  • NGS Strong Buy
  • Analyst Count
  • IMMP 1
  • NGS 3
  • Target Price
  • IMMP $7.00
  • NGS $33.67
  • AVG Volume (30 Days)
  • IMMP 88.5K
  • NGS 49.2K
  • Earning Date
  • IMMP 10-21-2025
  • NGS 11-13-2025
  • Dividend Yield
  • IMMP N/A
  • NGS 1.47%
  • EPS Growth
  • IMMP N/A
  • NGS 33.85
  • EPS
  • IMMP N/A
  • NGS 1.42
  • Revenue
  • IMMP $3,306,742.00
  • NGS $164,109,000.00
  • Revenue This Year
  • IMMP N/A
  • NGS $9.86
  • Revenue Next Year
  • IMMP $725.37
  • NGS $14.21
  • P/E Ratio
  • IMMP N/A
  • NGS $19.21
  • Revenue Growth
  • IMMP 31.28
  • NGS 14.77
  • 52 Week Low
  • IMMP $1.32
  • NGS $16.73
  • 52 Week High
  • IMMP $2.71
  • NGS $29.74
  • Technical
  • Relative Strength Index (RSI)
  • IMMP 49.09
  • NGS 56.40
  • Support Level
  • IMMP $1.60
  • NGS $26.25
  • Resistance Level
  • IMMP $1.76
  • NGS $26.89
  • Average True Range (ATR)
  • IMMP 0.06
  • NGS 0.74
  • MACD
  • IMMP 0.01
  • NGS 0.02
  • Stochastic Oscillator
  • IMMP 47.06
  • NGS 59.07

About IMMP Immutep Limited

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

About NGS Natural Gas Services Group Inc.

Natural Gas Services Group Inc provides natural gas compression equipment and services to the energy industry. The company manufactures, fabricates, rents, sells, and maintains natural gas compressors and flare systems for oil and natural gas production and plant facilities. Its operating units include Rental, Sales, and Aftermarket services. The company generates the majority of its revenue by renting out low- to medium-horsepower compression equipment to natural gas production companies in unconventional oil and gas regions of the United States.

Share on Social Networks: